Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
38 studies found for:    Open Studies | liver | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
Conditions: Liver Diseases;   Portal Hypertension
Intervention: Drug: SHAPE measurement (Sonazoid ultrasoud contrast agent)
22 Recruiting Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Conditions: Alpha-1-antitrypsin Deficiency;   Liver Cirrhosis
Interventions: Drug: Drug-Carbamazepine (Tegretol XR);   Drug: Carbamazepine (Tegretol XR) Placebo
23 Recruiting 13C-Methacetin Breath Test for the Prediction of Outcome in ALF
Condition: Acute Liver Failure
Intervention: Drug: 13C-methacetin
24 Recruiting Impact of Weight Loss Surgery in Adolescents With NAFLD
Conditions: NAFLD;   Obesity, Adolescent
Intervention: Other: MRI
25 Recruiting Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Condition: Chronic Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: GS-5816
26 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:
27 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
Intervention:
28 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
29 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
30 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
31 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
32 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
33 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & Emtricitabine;   Drug: Tenofovir
34 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
35 Recruiting Hepatitis B Research Network Adult Cohort Study
Condition: Hepatitis B
Intervention:
36 Recruiting Oral Iron for Erythropoietic Protoporphyrias
Conditions: Erythropoietic Protoporphyria;   EPP;   X-linked Protoporphyria;   XLP
Intervention: Drug: Oral Iron
37 Recruiting Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Conditions: Erythropoietic Protoporphyria;   EPP;   X-Linked Protoporphyria;   XLP;   XLPP;   X-Linked Dominant Erythropoietic Protoporphyria;   XLEPP;   XLDP
Intervention:
38 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Study has passed its completion date and status has not been verified in more than two years.